IL123667A0 - Pneumococcal genes portions thereof expression products therefrom and uses of such genes portions and products - Google Patents
Pneumococcal genes portions thereof expression products therefrom and uses of such genes portions and productsInfo
- Publication number
- IL123667A0 IL123667A0 IL12366796A IL12366796A IL123667A0 IL 123667 A0 IL123667 A0 IL 123667A0 IL 12366796 A IL12366796 A IL 12366796A IL 12366796 A IL12366796 A IL 12366796A IL 123667 A0 IL123667 A0 IL 123667A0
- Authority
- IL
- Israel
- Prior art keywords
- genes
- portions
- pneumococcal
- products
- products therefrom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K15/00—Arrangements for producing a permanent visual presentation of the output data, e.g. computer output printers
- G06K15/02—Arrangements for producing a permanent visual presentation of the output data, e.g. computer output printers using printers
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T9/00—Image coding
- G06T9/005—Statistical coding, e.g. Huffman, run length coding
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B20/00—Signal processing not specific to the method of recording or reproducing; Circuits therefor
- G11B20/10—Digital recording or reproducing
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B25/00—Apparatus characterised by the shape of record carrier employed but not specific to the method of recording or reproducing, e.g. dictating apparatus; Combinations of such apparatus
- G11B25/04—Apparatus characterised by the shape of record carrier employed but not specific to the method of recording or reproducing, e.g. dictating apparatus; Combinations of such apparatus using flat record carriers, e.g. disc, card
- G11B25/043—Apparatus characterised by the shape of record carrier employed but not specific to the method of recording or reproducing, e.g. dictating apparatus; Combinations of such apparatus using flat record carriers, e.g. disc, card using rotating discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B5/00—Recording by magnetisation or demagnetisation of a record carrier; Reproducing by magnetic means; Record carriers therefor
- G11B5/012—Recording on, or reproducing or erasing from, magnetic disks
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Theoretical Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Toxicology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/529,055 US6592876B1 (en) | 1993-04-20 | 1995-09-15 | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| PCT/US1996/014819 WO1997009994A1 (en) | 1995-09-15 | 1996-09-16 | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL123667A0 true IL123667A0 (en) | 1998-10-30 |
Family
ID=24108319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12366796A IL123667A0 (en) | 1995-09-15 | 1996-09-16 | Pneumococcal genes portions thereof expression products therefrom and uses of such genes portions and products |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6592876B1 (enExample) |
| EP (2) | EP1477185A2 (enExample) |
| JP (1) | JPH11513371A (enExample) |
| AT (1) | ATE322279T1 (enExample) |
| AU (1) | AU703434B2 (enExample) |
| CA (1) | CA2232033A1 (enExample) |
| DE (1) | DE69636017D1 (enExample) |
| FI (1) | FI980561A7 (enExample) |
| IL (1) | IL123667A0 (enExample) |
| NO (1) | NO981169L (enExample) |
| WO (1) | WO1997009994A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7078042B2 (en) * | 1995-09-15 | 2006-07-18 | Uab Research Foundation | Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| US6245335B1 (en) * | 1996-05-01 | 2001-06-12 | The Rockefeller University | Choline binding proteins for anti-pneumococcal vaccines |
| US5928895A (en) * | 1996-09-24 | 1999-07-27 | Smithkline Beecham Corporation | IgA Fc binding protein |
| CA2304128A1 (en) * | 1997-09-18 | 1999-03-25 | Robert Becker | Improved method of production of pneumococcal surface proteins |
| MXPA00009899A (es) * | 1998-04-07 | 2002-05-08 | St Jude Childrens Res Hospital | Polipeptido que comprende la secuencia de aminoacidos de un truncado n- terminal de proteina a de union a colina, vacuna derivada del mismo y usos del los mismos. |
| ES2343492T3 (es) | 1998-04-07 | 2010-08-02 | Medimmune, Llc | Derivados de proteinas neumococicas de union a colina para vacunas. |
| US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| AU2004200125B2 (en) * | 1998-04-07 | 2006-07-27 | Med Immune, Inc. | Derivatives of Pneumococcal Choline Binding Proteins for Vaccines |
| EP1073450A4 (en) * | 1998-04-23 | 2003-04-23 | Uab Research Foundation | PNEUMOCOCCAL SURFACE PROTEIN C (PSPC), EPITOPIC REGIONS, SELECTION OF CORRESPONDING STRES AND USES |
| US20010016200A1 (en) | 1998-04-23 | 2001-08-23 | Briles David E. | Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| US6908898B1 (en) * | 1998-06-15 | 2005-06-21 | Lars Holmgren | Angiogenesis related molecules |
| EP1790729A3 (en) * | 1998-07-27 | 2007-07-25 | Sanofi Pasteur Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
| US6936252B2 (en) | 1998-07-27 | 2005-08-30 | Microbial Technics Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
| EP1162999B1 (en) | 1999-03-19 | 2006-11-29 | Glaxosmithkline Biologicals S.A. | Vaccine against Streptococcus pneumoniae |
| GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
| BE1013344A3 (nl) * | 2000-03-08 | 2001-12-04 | Organic Waste Systems Nv | Werkwijze voor het behandelen van vast afval met een organische fr actie. |
| US20050165224A1 (en) * | 2000-03-20 | 2005-07-28 | Alexander Tomasz | Inhibition of penicillin resistance in s. pneumoniae |
| JP2004503565A (ja) * | 2000-06-14 | 2004-02-05 | サイトヴァックス・バイオテクノロジーズ・インコーポレーテッド | 構造特異的ペプチドを生産するためのコイルドコイル構造的骨格の使用 |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| DK2255826T3 (en) | 2002-08-02 | 2016-06-20 | Glaxosmithkline Biologicals Sa | Neisserial vaccine compositions comprising a combination of antigens. |
| HUE034801T2 (en) | 2002-11-01 | 2018-02-28 | Glaxosmithkline Biologicals Sa | Drying procedure |
| AU2004269320B2 (en) | 2003-06-20 | 2009-12-24 | Protein Sciences Corporation | Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| DE602004028262D1 (de) | 2003-10-02 | 2010-09-02 | Glaxosmithkline Biolog Sa | B. pertussis antigene und ihre verwendung bei der vakzinierung |
| JP2007512006A (ja) * | 2003-11-10 | 2007-05-17 | ザ ユーエービー リサーチ ファウンデーション | 細菌輸送およびcns侵襲を低減させるための組成物およびこの組成物を使用する方法 |
| WO2006097110A2 (en) * | 2005-03-18 | 2006-09-21 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
| GB0505996D0 (en) | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| PL3017827T3 (pl) | 2005-12-22 | 2019-04-30 | Glaxosmithkline Biologicals Sa | Szczepionka z koniugatem polisacharydu pneumokokowego |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| NO346497B1 (no) | 2006-01-17 | 2022-09-05 | Arne Forsgren | Overflateeksponert haemophilus influenzae protein (protein E, pE) |
| US8808704B2 (en) * | 2006-02-02 | 2014-08-19 | The Uab Research Foundation | Non-coiled protective regions of pneumococcal surface proteins PspA and PspC |
| AU2007285775B2 (en) * | 2006-08-17 | 2011-03-03 | Sanofi Pasteur Ltd. | Immunogenic PcpA polypeptides and uses thereof |
| AU2007353789B2 (en) * | 2007-05-23 | 2014-05-22 | The Uab Research Foundation | Detoxified pneumococcal neuraminidase and uses thereof |
| US9610339B2 (en) | 2007-06-26 | 2017-04-04 | Glaxosmithkline Biologicals, S.A. | Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates |
| US8052873B1 (en) * | 2007-10-31 | 2011-11-08 | Environmental Business Specialists, LLC | Bacterial cultivation system for growth of substrate specific micro-organisms for use in industrial wastewater remediation |
| PL2271360T3 (pl) | 2008-04-16 | 2016-03-31 | Glaxosmithkline Biologicals Sa | Szczepionka |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| JP2013521326A (ja) | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
| BR112013029514A2 (pt) | 2011-05-17 | 2019-09-24 | Glaxosmithkline Biologicals Sa | composição imunogênica, vacina, e, método de tratar ou impedir uma doença |
| CN102516373B (zh) * | 2011-12-30 | 2013-07-31 | 天津康希诺生物技术有限公司 | 去除人同源性的肺炎链球菌表面蛋白a、纯化方法及用途 |
| ES2763415T3 (es) | 2012-09-19 | 2020-05-28 | Univ Osaka | Vacuna neumocócica que contiene proteína A superficial neumocócica |
| GB201318170D0 (en) * | 2013-10-14 | 2013-11-27 | Univ Edinburgh | Proteins with Diagnostic and Therapeutic Uses |
| RU2737638C2 (ru) * | 2013-12-03 | 2020-12-01 | Вирометикс Аг | ПРОЛИН-БОГАТЫЕ ПЕПТИДЫ, ЗАЩИЩАЮЩИЕ ОТ S.pneumoniae |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| EP3387006A4 (en) | 2015-12-10 | 2019-05-08 | National Research Council of Canada | LIPIDATED STREPTOCOCCUS PNEUMONIAE |
| WO2017130222A1 (en) * | 2016-01-27 | 2017-08-03 | Magellan Life Sciences Private Limited | Process for extracellular secretion of brazzein |
| AU2017366726B2 (en) * | 2016-12-03 | 2021-12-09 | The Uab Research Foundation | Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A |
| WO2024227236A1 (en) * | 2023-04-30 | 2024-11-07 | Instituto Butantan | Recombinant protein, expression cassette, immunogenic composition and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4152413A (en) * | 1978-08-18 | 1979-05-01 | Chromalloy American Corporation | Oral vaccine for swine dysentery and method of use |
| GB8405530D0 (en) * | 1984-03-02 | 1984-04-04 | Lysons R J | Vaccine for swine dysentery |
| JP3215109B2 (ja) | 1991-02-15 | 2001-10-02 | ユーエイビー リサーチ ファウンデーション | 肺炎球菌タンパクの構造遺伝子 |
| US5980909A (en) * | 1991-02-15 | 1999-11-09 | Uab Research Foundation | Epitopic regions of pneumococcal surface protein A |
| IL103530A0 (en) * | 1991-10-25 | 1993-03-15 | Duphar Int Res | Treponema hyodysenteriae vaccine |
| AU4400293A (en) * | 1992-05-29 | 1993-12-30 | Janet Yother | Methods for obtaining and purifying cell-free pneumococcal surface proteins from (s. pneumoniae) and use thereof |
| CA2116261A1 (en) * | 1993-04-20 | 1994-10-21 | David E. Briles | Epitopic regions of pneumococcal surface protein a |
| US5698394A (en) * | 1994-06-01 | 1997-12-16 | Board Of Regents Of The University Of Nebraska | Nucleotide sequences and methods for detection of Serpulina hyodysenteriae |
-
1995
- 1995-09-15 US US08/529,055 patent/US6592876B1/en not_active Expired - Fee Related
-
1996
- 1996-09-16 FI FI980561A patent/FI980561A7/fi not_active IP Right Cessation
- 1996-09-16 WO PCT/US1996/014819 patent/WO1997009994A1/en not_active Ceased
- 1996-09-16 CA CA002232033A patent/CA2232033A1/en not_active Abandoned
- 1996-09-16 AT AT96933794T patent/ATE322279T1/de not_active IP Right Cessation
- 1996-09-16 EP EP04077290A patent/EP1477185A2/en not_active Withdrawn
- 1996-09-16 JP JP9512172A patent/JPH11513371A/ja not_active Ceased
- 1996-09-16 AU AU72392/96A patent/AU703434B2/en not_active Ceased
- 1996-09-16 US US08/714,741 patent/US6500613B1/en not_active Expired - Fee Related
- 1996-09-16 IL IL12366796A patent/IL123667A0/xx unknown
- 1996-09-16 DE DE69636017T patent/DE69636017D1/de not_active Expired - Lifetime
- 1996-09-16 EP EP96933794A patent/EP0946188B1/en not_active Expired - Lifetime
-
1998
- 1998-03-16 NO NO981169A patent/NO981169L/no not_active Application Discontinuation
-
2002
- 2002-11-19 US US10/299,636 patent/US20040077847A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11513371A (ja) | 1999-11-16 |
| EP1477185A2 (en) | 2004-11-17 |
| EP0946188A4 (en) | 2003-05-02 |
| ATE322279T1 (de) | 2006-04-15 |
| DE69636017D1 (de) | 2006-05-18 |
| AU7239296A (en) | 1997-04-01 |
| EP0946188A1 (en) | 1999-10-06 |
| NO981169D0 (no) | 1998-03-16 |
| FI980561L (fi) | 1998-05-13 |
| US6500613B1 (en) | 2002-12-31 |
| EP0946188B1 (en) | 2006-04-05 |
| FI980561A7 (fi) | 1998-05-13 |
| AU703434B2 (en) | 1999-03-25 |
| CA2232033A1 (en) | 1997-03-20 |
| FI980561A0 (fi) | 1998-03-13 |
| US6592876B1 (en) | 2003-07-15 |
| NO981169L (no) | 1998-05-15 |
| WO1997009994A1 (en) | 1997-03-20 |
| US20040077847A1 (en) | 2004-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL123667A0 (en) | Pneumococcal genes portions thereof expression products therefrom and uses of such genes portions and products | |
| FR2637612B1 (fr) | Sequences de nucleotides codant pour une proteine a activite ureasique | |
| AU692678B2 (en) | Structural gene of pneumococcal protein | |
| WO1999033982A3 (en) | Human genes and gene expression products i | |
| NZ235478A (en) | Peptide or protein with phytase activity; dna encoding it; expression constructs; vectors; transformed host cells and animal feeds containing the peptide or protein | |
| WO1999058675A3 (en) | Human genes and gene expression products v | |
| WO1995018830A3 (en) | Inhibitors of human plasmin derived from the kunitz domains | |
| WO1999038972A8 (en) | Human genes and gene expression products ii | |
| EP1553182A3 (en) | Regulated genes and uses thereof | |
| EP0804609A4 (en) | NEW GENES OF RESPONSE p53 | |
| NL300271I1 (nl) | DNA dat humaan papillomavirus type 18 codeert. | |
| CA2115049A1 (en) | Dna sequences encoding gelonin polypeptide | |
| DE69331484D1 (de) | N-Acetylglucosaminyl-Transferase, dafür kodierendes Gen, entsprechende Vektoren und transformierte Wirte und Herstellungsverfahren dafür | |
| AU3802595A (en) | Tripeptidyl aminopeptidase | |
| PT759469E (pt) | Bacteriocina | |
| CA2170515A1 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
| AU7489098A (en) | Polypeptides having aminopeptidase activity and nucleic acids encoding same | |
| WO1998039450A3 (de) | Oberflächenprotein (spsa-protein) von streptococcus pneumoniae deletierte abkömmlinge, expressionssssystem für diese proteine und vaccine mit den proteinen | |
| DE69619808D1 (de) | Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän | |
| AU5727099A (en) | A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme | |
| AU3711597A (en) | A novel galanin receptor | |
| AU6134596A (en) | Enamel matrix related polypeptide | |
| WO2000018916A3 (en) | Human genes and gene expression products | |
| WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| MXPA01001639A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. |